Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high2,346.0 16/03/17
52 week low1,101.0 17/08/17
52 week change -1,095.0 (-47.36%)
4 week volume19,954,887 28/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - Goldman Sachs issues a broker note on Hikma Pharmaceuticals PLC

Goldman Sachs today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from buy...

Stockwatch: Is this a coiled spring or a falling knife?

It's likely private investors are eyeing this mid cap up but sitting on their hands for now. This could be of interest to vigilan...

Peel Hunt cuts earnings by 30% for Hikma

Peel Hunt has cut its earnings by 30% for Hikma Pharma (LON:HIK), while the price target falls to 13.90 from 21.50. The do...

Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLC

Morgan Stanley today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to equal weight (from...

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its p...

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target t...

FTSE remains weak on underwhelming financial stocks

Financial stocks continued to weigh on the FTSE 100, down 0.6% at 7,387. Standard Chartered (STAN) declined 2.7% to 755p...

Down 50% since March but still a 'buy'

This FTSE 250 pharma has seen half its value wiped off in just five months. But Graeme Evans finds one positive analyst ...

Fundamental DataMore

P/E ratio18.301
EPS66.5
Dividend yield2.712 %

Latest discussion posts More

  • Re: raising prices

    Yes they can charge what they like, BUT the healthcare insurance companies can direct that a much cheaper alternative is used/supplied. The price hike strategy can backfire ...
    22-Aug-2017
    Proverbs 26 vs 5
  • raising prices

    Are they allowed to raise prices 430% This seems excessive.
    21-Aug-2017
    susanne9
  • Hikma raises prices in US

    Hikma?s US unit sharply raises prices of several drugs West-Ward increase cost of medicines by as much as 430% Hikma, the London-listed generic drugmaker, has sharply ...
    20-Aug-2017
    Thedarkkn1ght

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..
LLOYDS GRP.36%
GLAXOSMITHKLINE28%
RDS 'B'23%
BP23%
BT GROUP22%

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK